feed,title,long_url,short_url
Benzinga,"Solid Bio's DMD Gene Therapy Shows Promising Early Data, No New Safety Concerns, But Fails To Cheer Investors",https://benzinga.com/general/biotech/21/03/20185645/solid-bios-dmd-gene-therapy-shows-promising-early-data-no-new-safety-concerns-but-fails-to-cheer-,https://j.mp/3eO3yU3
